Centre de Regulació Genòmica, Dr. Aiguader 88, 08003 Barcelona, Spain; Universitat Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain.
Centre de Regulació Genòmica, Dr. Aiguader 88, 08003 Barcelona, Spain; Universitat Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats, Pg Lluis Companys, 23, 08003 Barcelona, Spain.
Mol Cell. 2015 Jan 8;57(1):23-38. doi: 10.1016/j.molcel.2014.10.029. Epub 2014 Dec 4.
Alternative splicing of Fas/CD95 exon 6 generates either a membrane-bound receptor that promotes, or a soluble isoform that inhibits, apoptosis. Using an automatized genome-wide siRNA screening for alternative splicing regulators of endogenous transcripts in mammalian cells, we identified 200 genes whose knockdown modulates the ratio between Fas/CD95 isoforms. These include classical splicing regulators; core spliceosome components; and factors implicated in transcription and chromatin remodeling, RNA transport, intracellular signaling, and metabolic control. Coherent effects of genes involved in iron homeostasis and pharmacological modulation of iron levels revealed a link between intracellular iron and Fas/CD95 exon 6 inclusion. A splicing regulatory network linked iron levels with reduced activity of the Zinc-finger-containing splicing regulator SRSF7, and in vivo and in vitro assays revealed that iron inhibits SRSF7 RNA binding. Our results uncover numerous links between cellular pathways and RNA processing and a mechanism by which iron homeostasis can influence alternative splicing.
Fas/CD95 外显子 6 的可变剪接产生促进凋亡的膜结合受体,或抑制凋亡的可溶性同工型。我们使用自动化的全基因组 siRNA 筛选技术,在哺乳动物细胞中筛选内源性转录物的可变剪接调节剂,鉴定了 200 个基因,这些基因的敲低可调节 Fas/CD95 同工型的比例。这些基因包括经典剪接调节剂、核心剪接体成分;以及涉及转录和染色质重塑、RNA 运输、细胞内信号转导和代谢控制的因子。涉及铁稳态的基因和铁水平的药理学调节的一致作用表明细胞内铁与 Fas/CD95 外显子 6 包含之间存在联系。一个剪接调控网络将铁水平与含锌指的剪接调控因子 SRSF7 的活性降低联系起来,体内和体外实验表明铁抑制 SRSF7 RNA 结合。我们的结果揭示了细胞通路和 RNA 加工之间的许多联系,以及铁稳态如何影响可变剪接的机制。